378 related articles for article (PubMed ID: 27846309)
1. Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?
Hwong WY; Bots ML; Selvarajah S; Abdul Aziz Z; Sidek NN; Spiering W; Kappelle LJ; Vaartjes I
PLoS One; 2016; 11(11):e0166524. PubMed ID: 27846309
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
[TBL] [Abstract][Full Text] [Related]
3. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
[TBL] [Abstract][Full Text] [Related]
4. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
Talbert RL
J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive drugs for elderly patients: a cross- sectional study.
Lim KK; Sivasampu S; Khoo EM
Singapore Med J; 2015 May; 56(5):291-7. PubMed ID: 25597751
[TBL] [Abstract][Full Text] [Related]
6. Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Margariti E; Savopoulos C; Hatzitolios AI
Clin Exp Hypertens; 2017; 39(3):246-250. PubMed ID: 28448189
[TBL] [Abstract][Full Text] [Related]
7. Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.
Cataldi M; di Geronimo O; Trio R; Scotti A; Memoli A; Capone D; Guida B
BMC Pharmacol Toxicol; 2016 Mar; 17():9. PubMed ID: 26980335
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis.
Ren L; Yu S; Xu W; Overton JL; Chiamvimonvat N; Thai PN
J Cardiol; 2021 May; 77(5):482-491. PubMed ID: 33168337
[TBL] [Abstract][Full Text] [Related]
9. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Jeffers BW; Robbins J; Bhambri R
Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
[TBL] [Abstract][Full Text] [Related]
12. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
13. Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database.
Kim HL; Hwang D; Lee JH; Lee HY; Ihm SH; Kim KI; Shin J; Park S; Kim DH; Sung KC
Hypertens Res; 2022 May; 45(5):758-768. PubMed ID: 35338336
[TBL] [Abstract][Full Text] [Related]
14. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities.
Ishida T; Oh A; Hiroi S; Shimasaki Y; Tsuchihashi T
Clin Exp Hypertens; 2019; 41(3):203-210. PubMed ID: 29781721
[TBL] [Abstract][Full Text] [Related]
15. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
16. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials.
Chen GJ; Yang MS
PLoS One; 2013; 8(3):e57854. PubMed ID: 23483932
[TBL] [Abstract][Full Text] [Related]
17. Prestroke treatment with beta-blockers for hypertension is not associated with severity and poor outcome in patients with ischemic stroke: data from a national stroke registry.
Koton S; Tanne D; Grossman E
J Hypertens; 2017 Apr; 35(4):870-876. PubMed ID: 28030430
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive treatment and risk of atrial fibrillation: a nationwide study.
Marott SC; Nielsen SF; Benn M; Nordestgaard BG
Eur Heart J; 2014 May; 35(18):1205-14. PubMed ID: 24347316
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive drug therapies and the risk of ischemic stroke.
Klungel OH; Heckbert SR; Longstreth WT; Furberg CD; Kaplan RC; Smith NL; Lemaitre RN; Leufkens HG; de Boer A; Psaty BM
Arch Intern Med; 2001 Jan; 161(1):37-43. PubMed ID: 11146696
[TBL] [Abstract][Full Text] [Related]
20. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study.
Ohishi M; Yoshida T; Oh A; Hiroi S; Takeshima T; Otsuka Y; Iwasaki K; Shimasaki Y
Hypertens Res; 2019 Jul; 42(7):1057-1067. PubMed ID: 30842611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
